Bae, Sung Kwan <br/><br/>
HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center.  [electronic resource] 

 -  Bone marrow transplantation  04 2019 
 - 629-631 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/s41409-018-0355-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Female<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Hepatitis B--virology<br/>Hepatitis B virus--physiology<br/>Humans<br/>Male<br/>Middle Aged<br/>Rituximab--administration & dosage<br/>Transplantation Conditioning--adverse effects<br/>Virus Activation